Shorter and more effective treatment options for hepatitis C with two new pill-only antiviral drug regimens is now available. This treatment could have fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, suggest the results of two studies published in iThe Lancet/i. Both studies focused on hepatitis C genotype 1, which is the most common genotype in the USA, Europe, North Asia, Australia, and South America, ...
Read More
No comments:
Post a Comment